Fig. 4From: Cost-effectiveness of using artificial intelligence versus polygenic risk score to guide breast cancer screeningTornado Diagram. Costs and utilities are varied in a range of ±25% of base case values. ICER: Incremental Cost-Effectiveness RatioBack to article page